Evidence map›Paper›PMID 30217142›Full record

ArticleInfectious diseases of poverty2018

Effective surveillance systems for vector-borne diseases in urban settings and translation of the data into action: a scoping review.

Florence Fournet, Frédéric Jourdain, Emmanuel Bonnet, Stéphanie Degroote, Valéry Ridde

Open access · goldAbstract readScoping Review
In one paragraph

Article in Infectious diseases of poverty, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed, 1 pooled it
8.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 1 synthesis or guideline pooled it, 85 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Epidemiology of malaria in saravan city and its suburbs from 2018 to 2023, Southeast Iran.Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 5 institutions in 2 countries.

Florence FournetInfectious Diseases and Vectors Ecology, Genetics, Evolution and Control (MIVEGEC), French National Research Institute for Sustainable Development, 911 Avenue Agropolis, BP 64501, 34394, Montpellier Cedex 5, France. florence.fournet@ird.fr.ORCID http://orcid.org/0000-0003-0220-8131
Frédéric JourdainInfectious Diseases and Vectors Ecology, Genetics, Evolution and Control (MIVEGEC), French National Research Institute for Sustainable Development, 911 Avenue Agropolis, BP 64501, 34394, Montpellier Cedex 5, France.
Emmanuel BonnetRésiliences, French National Research Institute for Sustainable Development, 32 Avenue Henri Varagnat, 93140, Bondy, France.
Stéphanie DegrooteUniversity of Montreal, Public Health Research Institute, 7101 avenue du Parc, Montréal, Québec, Canada.
Valéry RiddeUniversity of Montreal, Public Health Research Institute, 7101 avenue du Parc, Montréal, Québec, Canada.
Agropolis International · FRCentre Population et Développement · FRInstitut de Recherche pour le Développement · FRMaladies Infectieuses et Vecteurs: Écologie, Génétique, Évolution et Contrôle · FRUniversité de Montréal · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundVector-borne diseases (VBDs) continue to represent a global threat, with "old" diseases like malaria, and "emergent" or "re-emergent" ones like Zika, because of an increase in international trade, demographic growth, and rapid urbanization. In this era of globalization, surveillance is a key element in controlling VBDs in urban settings, but surveillance alone cannot solve the problem. A review of experiences is of interest to examine other solution elements. The objectives were to assess the different means of VBD surveillance in urban environments, to evaluate their potential for supporting public health actions, and to describe the tools used for public health actions, the constraints they face, and the research and health action gaps to be filled. MAIN BODY: For this scoping review we searched peer-reviewed articles and grey literature published between 2000 and 2016. Various tools were used for data coding and extraction. A quality assessment was done for each study reviewed, and descriptive characteristics and data on implementation process and transferability were analyzed in all studies. After screening 414 full-text articles, we retained a total of 79 articles for review. The main targets of the articles were arboviral diseases (65.8%) and malaria (16.5%). The positive aspects of many studies fit within the framework of integrated vector management. Public awareness is considered a key to successful vector control programs. Advocacy and legislation can reinforce both empowerment and capacity building. These can be achieved by collaboration within the health sector and with other sectors. Research is needed to develop well designed studies and new tools for surveillance and control.

conclusionsThe need for surveillance systems in urban settings in both developing and developed countries was highlighted. Countries face the same challenges relating to human, financial, and structural resources. These findings also constitute a wake-up call for governments, academia, funders, and World Health Organization to strengthen control programs and enhance VBD research in urban environments.

Indexed as

Sentinel SurveillanceUrban HealthAnimalsDisease VectorsHumansInfection ControlInfectionsPublic HealthScoping reviewSurveillance systemsUrban healthVector-borne diseases

Identifiers

PMID30217142
PMCPMC6137924
OpenAlexW2889764510

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.